Table 4. Inter-Observer Agreement between Two Reviewers on the Initial Staging, Resectability Assessment, and Follow-Up after Surgical Resection.
| CT | CT + PET/MRI | |
|---|---|---|
| Initial workup | ||
| Likelihood of malignancy | 0.55 (0.36–0.74) | 0.49 (0.24–0.73) |
| Local resectability | 0.45 (0.30–0.60) | 0.55 (0.40–0.70) |
| Distant lymph node metastasis | 0.44 (0.27–0.61) | 0.75 (0.64–0.87) |
| Hepatic metastasis | 0.51 (0.31–0.72) | 0.60 (0.45–0.75) |
| Peritoneal seeding | 0.61 (0.39–0.82) | 0.76 (0.55–0.97) |
| Overall resectability | 0.57 (0.42–0.71) | 0.83 (0.72–0.94) |
| Follow-up after surgical resection | ||
| Local recurrence | 0.72 (0.53–0.91) | 0.85 (0.75–0.96) |
| Distant lymph node metastasis | 0.82 (0.65–0.98) | 0.90 (0.79–1.00) |
| Hepatic metastasis | 0.74 (0.58–0.90) | 0.79 (0.61–0.96) |
| Peritoneal seeding | 0.83 (0.66–1.00) | 0.75 (0.51–0.99) |
Data are shown as linear-weighted kappa values. The numbers in parentheses are 95% confidence intervals.